JP2001508028A - チアゾリジノンの投与による神経変性疾患の処置および予防方法 - Google Patents
チアゾリジノンの投与による神経変性疾患の処置および予防方法Info
- Publication number
- JP2001508028A JP2001508028A JP50606698A JP50606698A JP2001508028A JP 2001508028 A JP2001508028 A JP 2001508028A JP 50606698 A JP50606698 A JP 50606698A JP 50606698 A JP50606698 A JP 50606698A JP 2001508028 A JP2001508028 A JP 2001508028A
- Authority
- JP
- Japan
- Prior art keywords
- thiazolidinone
- disease
- eae
- treated
- neurodegenerative diseases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.神経変性疾患の処置および予防方法において、このような処置を必要とする 患者に、5−[[3,5−ビス−(1,1−ジメチルエチル)−4−ヒドロキシフェニル] メチレン]−2−イミノ−4−チアゾリジノンまたはその医薬的に許容される塩 の有効量を投与することからなる方法。 2.使用される化合物はメタンスルホン酸塩の形態である請求項1記載の方法. 3.使用される化合物は(Z)−5−[[3,5−ビス−(1,1−ジメチルエチル)−4− ヒドロキシフェニル]メチレン]−2−イミノ−4−チアゾリジノンメタンスルホ ン酸塩である請求項1記載の方法。 4.処置される疾患はアルツハイマー病である請求項1記載の方法。 5.処置される疾患は多発性硬化症である請求項1記載の方法。 6.処置される疾患は卒中である請求項1記載の方法。 7.処置される疾患は頭部傷害である請求項1記載の方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2157196P | 1996-07-11 | 1996-07-11 | |
US60/021,571 | 1996-07-11 | ||
PCT/US1997/011586 WO1998002160A1 (en) | 1996-07-11 | 1997-07-01 | Method for treating and preventing neurodegenerative disorders by administering a thiazolidinone |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2001508028A true JP2001508028A (ja) | 2001-06-19 |
JP2001508028A5 JP2001508028A5 (ja) | 2005-03-10 |
Family
ID=21804973
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP50606698A Ceased JP2001508028A (ja) | 1996-07-11 | 1997-07-01 | チアゾリジノンの投与による神経変性疾患の処置および予防方法 |
Country Status (23)
Country | Link |
---|---|
US (1) | US5912259A (ja) |
EP (1) | EP0914122B1 (ja) |
JP (1) | JP2001508028A (ja) |
KR (1) | KR20000023683A (ja) |
CN (1) | CN1145481C (ja) |
AT (1) | ATE250416T1 (ja) |
AU (1) | AU726664B2 (ja) |
BR (1) | BR9710467A (ja) |
CA (1) | CA2255073A1 (ja) |
CO (1) | CO4940509A1 (ja) |
DE (1) | DE69725147T2 (ja) |
DK (1) | DK0914122T3 (ja) |
ES (1) | ES2205247T3 (ja) |
HK (1) | HK1020533A1 (ja) |
HR (1) | HRP970362A2 (ja) |
IL (1) | IL127487A (ja) |
NO (1) | NO990076L (ja) |
NZ (1) | NZ332763A (ja) |
PL (1) | PL331049A1 (ja) |
PT (1) | PT914122E (ja) |
TR (1) | TR199900040T2 (ja) |
WO (1) | WO1998002160A1 (ja) |
ZA (1) | ZA976142B (ja) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7410797B2 (en) * | 2002-06-11 | 2008-08-12 | Ogle Roy C | Meningeal-derived stem cells |
US20110104296A1 (en) * | 2008-05-08 | 2011-05-05 | Dipak Kumar Sarkar | Endorphin Therapy Compositions and Methods |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL79648A (en) * | 1985-08-09 | 1991-12-12 | Lilly Co Eli | Pharmaceutical anti-inflammatory and ischemia preventing compositions containing di-t-butylphenol derivatives,some such novel compounds and process for their preparation |
DE69027472T2 (de) * | 1989-04-07 | 1996-12-05 | Lilly Co Eli | Arylsubstituierte Rhodaninderivate |
US5143928A (en) * | 1990-03-27 | 1992-09-01 | Warner-Lambert Company | 3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of 2-substituted thiazolidinones, oxazolidinones, and imidazolidinones as antiinflammatory agents |
US5192753A (en) * | 1991-04-23 | 1993-03-09 | Mcgeer Patrick L | Anti-rheumatoid arthritic drugs in the treatment of dementia |
EP0587377A3 (en) * | 1992-09-10 | 1994-09-21 | Lilly Co Eli | Thiazolidinone derivatives as hypoglycemic agents and for treating alzheimer's disease |
WO1996022772A1 (en) * | 1995-01-23 | 1996-08-01 | Eli Lilly And Company | Method for treating multiple sclerosis |
DE69635048T2 (de) * | 1995-06-12 | 2006-02-16 | G.D. Searle & Co. | Mittel, enthaltend einen cyclooxygenase-2 inhibitor und einen 5-lipoxygenase inhibitor |
-
1997
- 1997-07-01 PL PL97331049A patent/PL331049A1/xx unknown
- 1997-07-01 BR BR9710467A patent/BR9710467A/pt not_active Application Discontinuation
- 1997-07-01 NZ NZ332763A patent/NZ332763A/xx unknown
- 1997-07-01 TR TR1999/00040T patent/TR199900040T2/xx unknown
- 1997-07-01 IL IL12748797A patent/IL127487A/en not_active IP Right Cessation
- 1997-07-01 DK DK97933264T patent/DK0914122T3/da active
- 1997-07-01 EP EP97933264A patent/EP0914122B1/en not_active Expired - Lifetime
- 1997-07-01 CN CNB971960429A patent/CN1145481C/zh not_active Expired - Fee Related
- 1997-07-01 AT AT97933264T patent/ATE250416T1/de not_active IP Right Cessation
- 1997-07-01 PT PT97933264T patent/PT914122E/pt unknown
- 1997-07-01 US US09/171,891 patent/US5912259A/en not_active Expired - Fee Related
- 1997-07-01 CA CA002255073A patent/CA2255073A1/en not_active Abandoned
- 1997-07-01 JP JP50606698A patent/JP2001508028A/ja not_active Ceased
- 1997-07-01 AU AU36491/97A patent/AU726664B2/en not_active Ceased
- 1997-07-01 ES ES97933264T patent/ES2205247T3/es not_active Expired - Lifetime
- 1997-07-01 DE DE69725147T patent/DE69725147T2/de not_active Expired - Fee Related
- 1997-07-01 WO PCT/US1997/011586 patent/WO1998002160A1/en active IP Right Grant
- 1997-07-03 HR HR60/021,571A patent/HRP970362A2/xx not_active Application Discontinuation
- 1997-07-10 ZA ZA9706142A patent/ZA976142B/xx unknown
- 1997-07-10 CO CO97038493A patent/CO4940509A1/es unknown
-
1999
- 1999-01-08 NO NO990076A patent/NO990076L/no not_active Application Discontinuation
- 1999-01-09 KR KR1019997000140A patent/KR20000023683A/ko active IP Right Grant
- 1999-11-30 HK HK99105554A patent/HK1020533A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
WO1998002160A1 (en) | 1998-01-22 |
IL127487A0 (en) | 1999-10-28 |
AU3649197A (en) | 1998-02-09 |
NO990076D0 (no) | 1999-01-08 |
DE69725147T2 (de) | 2004-07-22 |
NO990076L (no) | 1999-01-08 |
ZA976142B (en) | 1998-02-02 |
CO4940509A1 (es) | 2000-07-24 |
HRP970362A2 (en) | 1998-04-30 |
HK1020533A1 (en) | 2000-05-12 |
ATE250416T1 (de) | 2003-10-15 |
TR199900040T2 (xx) | 1999-04-21 |
US5912259A (en) | 1999-06-15 |
BR9710467A (pt) | 1999-08-17 |
EP0914122A1 (en) | 1999-05-12 |
ES2205247T3 (es) | 2004-05-01 |
CA2255073A1 (en) | 1998-01-22 |
PT914122E (pt) | 2003-12-31 |
EP0914122B1 (en) | 2003-09-24 |
IL127487A (en) | 2002-04-21 |
DK0914122T3 (da) | 2003-12-22 |
CN1145481C (zh) | 2004-04-14 |
NZ332763A (en) | 2000-07-28 |
PL331049A1 (en) | 1999-06-21 |
CN1223582A (zh) | 1999-07-21 |
AU726664B2 (en) | 2000-11-16 |
DE69725147D1 (de) | 2003-10-30 |
KR20000023683A (ko) | 2000-04-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11690831B2 (en) | Treatment of autoimmune diseases with combinations of RXR agonists and thyroid hormones | |
US20230129034A1 (en) | Treatment of disease with esters of selective rxr agonists | |
JP2016517883A (ja) | X連鎖副腎白質ジストロフィーの処置におけるソベチロムの使用 | |
KR20070116632A (ko) | 프로스타글란딘 F2a 유도체를 유효 성분으로서 함유하는망막신경세포 보호제 | |
NL8802634A (nl) | Therapeutische preparaten. | |
JPH05505189A (ja) | 3―グアニジノプロピオン酸の代謝障害の治療用組成物 | |
JP2003519653A (ja) | 乾癬の治療用の物質 | |
CN113795250A (zh) | 关节炎疾病的联合治疗 | |
WO2000035867A1 (fr) | Nouveaux ligands d'un recepteur nucleaire | |
RU2727142C2 (ru) | Бисамидное производное дикарбоновой кислоты в качестве средства, стимулирующего регенерацию тканей и восстановление сниженных функций тканей | |
EA001325B1 (ru) | Способы лечения и профилактики интерстициального цистита | |
JP2001508028A (ja) | チアゾリジノンの投与による神経変性疾患の処置および予防方法 | |
JP2007513173A (ja) | ロシグリタゾンを用いる乾癬の治療 | |
WO2018051355A1 (en) | Tamoxifen or tamoxifen in combination with arginine/citrulline for the use in the treatment of muscular dystrophy | |
US11147798B2 (en) | Use of carbamate compound for prevention, alleviation, or treatment of demyelinating disease | |
JP2008513430A (ja) | 月経前症候群および月経前不快気分障害の処置のためのピンドロール | |
JP7204477B2 (ja) | 遅発相アレルギー反応抑制剤 | |
TW202116297A (zh) | 組合療法之方法、組成物與套組 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20040701 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20040701 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20080415 |
|
A313 | Final decision of rejection without a dissenting response from the applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A313 Effective date: 20080909 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20081104 |